Appendix 4E and 2026 Annual Report
Filed with ASX · · 94 pages · English
Story so far
Earlier from Dimerix
- Appendix 4G and Corporate Governance Statement
- Dimerix Receives US$10M Upfront Payment from Everest
- Dimerix Assumes Sponsorship of US IND for New Asset DMX-652
- Dimerix Presents at Bioshares Summit 2026
- Dimerix Quarterly Activities Report and Appendix 4C
Later from Dimerix
- Trading Halt
- Dimerix Secures A$34 Million Non-Dilutive Funding Facility
- Dimerix secures a$34 million non-dilutive facility to fund key clinical milestones
- S&P DJI Announces September 2026 Quarterly Rebalance
- Dimerix Investor Presentation
Follow Dimerix into a list and get an email when it puts out news.
Follow Dimerix